Cocrystal Pharma
Tracked across 1 events · 6 articles · First seen Apr 02, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Cocrystal Pharma received Fast Track designation from the FDA for its oral antiviral candidate, CDI-988, for norovirus infection, which is a significant milestone for the company and led to a substantial jump in its stock price.
Apr 02, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Cocrystal Pharma live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard